NRG1 and Tremor: Moreover, treatment with a combination of both anti-ErbB3 and anti-ErbB4 inhibitory antibodies did not result in tremor or sensorimotor gating deficits, further supporting a receptor-independent mechanism of the anti-NRG1 phenotypes.